FDA Approves DIGOXIN — Sandoz Inc

Sandoz Inc. announced the launch of generic digoxin injection in follow-on to an August 21, 2003, FDA approval, following a standard ANDA filing. Market analysts welcomed the move as a strategic addition to Sandoz’s portfolio, anticipating a competitive shift in the intramuscular cardiovascular drug segment and increased price accessibility for facilities currently prescribing the brand name.